Trials / Recruiting
RecruitingNCT07446816
A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181
A Phase Ib Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181 in Patients With Advanced Solid Tumours
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Ganzhou Hemay Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
An open-label phase I clinical study,which enrolled subjects with advanced solid tumors who have failed to respond to adequate standard therapies or have no available effective standard therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hemay181 | intravenous infusion，once every 3 weeks |
Timeline
- Start date
- 2025-12-03
- Primary completion
- 2026-08-01
- Completion
- 2027-08-01
- First posted
- 2026-03-03
- Last updated
- 2026-03-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07446816. Inclusion in this directory is not an endorsement.